首页 > 最新文献

Anesthesia and pain medicine最新文献

英文 中文
Retrospective analysis of the feasibility and safety of external jugular vein cannulation in surgical patients. 回顾性分析手术患者颈外静脉置管的可行性及安全性。
Pub Date : 2023-01-01 DOI: 10.17085/apm.22171
Jae-Woo Ju, Yoonbin Hwang, Ho-Jin Lee

Background: Establishing intravenous (IV) access is an essential procedure in surgical patients. External jugular vein (EJV) cannulation can be a good alternative for patients forwhom it is difficult to establish peripheral IV access. We aimed to investigate the feasibilityand safety of EJV cannulation in surgical patients.

Methods: We performed a retrospective review of EJV cannulation in patients who underwent anesthesia for surgery at a tertiary hospital between 2010 and 2021. We collectedclinical characteristics, including EJV cannulation-related variables, from the anesthetic records. We also investigated the EJV cannulation-related complications, which included anyEJV cannulation-related complications (insertion site swelling, infection, thrombophlebitis,pneumothorax, and arterial cannulation) within 7 days after surgery, from the electronicmedical records during the hospitalization period for surgery.

Results: We analyzed 9,482 cases of 9,062 patients for whom EJV cannulation was performed during anesthesia. The most commonly performed surgery was general surgery(49.6%), followed by urologic surgery (17.5%) and obstetric and gynecologic surgery (15.7%).Unplanned EJV cannulation was performed emergently during surgery for 878 (9.3%) cases.The only EJV cannulation-related complication was swelling at the EJV-cannula insertion site(65 cases, 0.7%). There was only one case of unplanned intensive care unit admission dueto swelling related to EJV cannulation.

Conclusions: Our study showed the feasibility and safety of EJV cannulation for surgical patients with difficult IV access or those who need additional large-bore IV access during surgery. EJV cannulation can provide safe and reliable IV access with a low risk of major complications in a surgical patient.

背景:建立静脉(IV)通道是外科患者的基本程序。对于难以建立外周静脉通路的患者,颈外静脉(EJV)插管是一个很好的选择。我们的目的是探讨EJV插管在外科患者中的可行性和安全性。方法:我们对2010年至2021年在一家三级医院接受手术麻醉的患者进行了EJV插管的回顾性研究。我们从麻醉记录中收集临床特征,包括EJV插管相关变量。我们还调查了手术住院期间电子病历中的EJV插管相关并发症,包括术后7天内EJV插管相关并发症(插入部位肿胀、感染、血栓性静脉炎、气胸和动脉插管)。结果:我们分析了9,482例9,062例在麻醉状态下进行EJV插管的患者。最常见的手术是普外科(49.6%),其次是泌尿外科(17.5%)和妇产科(15.7%)。878例(9.3%)患者在手术期间紧急进行了计划外EJV插管。唯一与EJV套管相关的并发症是EJV套管插入部位肿胀(65例,0.7%)。只有1例因EJV插管引起的肿胀而非计划入住重症监护病房。结论:我们的研究表明,EJV插管对于静脉输注困难或术中需要额外大口径静脉输注的手术患者是可行和安全的。EJV插管可以为外科患者提供安全可靠的静脉注射通道,并降低主要并发症的风险。
{"title":"Retrospective analysis of the feasibility and safety of external jugular vein cannulation in surgical patients.","authors":"Jae-Woo Ju,&nbsp;Yoonbin Hwang,&nbsp;Ho-Jin Lee","doi":"10.17085/apm.22171","DOIUrl":"https://doi.org/10.17085/apm.22171","url":null,"abstract":"<p><strong>Background: </strong>Establishing intravenous (IV) access is an essential procedure in surgical patients. External jugular vein (EJV) cannulation can be a good alternative for patients forwhom it is difficult to establish peripheral IV access. We aimed to investigate the feasibilityand safety of EJV cannulation in surgical patients.</p><p><strong>Methods: </strong>We performed a retrospective review of EJV cannulation in patients who underwent anesthesia for surgery at a tertiary hospital between 2010 and 2021. We collectedclinical characteristics, including EJV cannulation-related variables, from the anesthetic records. We also investigated the EJV cannulation-related complications, which included anyEJV cannulation-related complications (insertion site swelling, infection, thrombophlebitis,pneumothorax, and arterial cannulation) within 7 days after surgery, from the electronicmedical records during the hospitalization period for surgery.</p><p><strong>Results: </strong>We analyzed 9,482 cases of 9,062 patients for whom EJV cannulation was performed during anesthesia. The most commonly performed surgery was general surgery(49.6%), followed by urologic surgery (17.5%) and obstetric and gynecologic surgery (15.7%).Unplanned EJV cannulation was performed emergently during surgery for 878 (9.3%) cases.The only EJV cannulation-related complication was swelling at the EJV-cannula insertion site(65 cases, 0.7%). There was only one case of unplanned intensive care unit admission dueto swelling related to EJV cannulation.</p><p><strong>Conclusions: </strong>Our study showed the feasibility and safety of EJV cannulation for surgical patients with difficult IV access or those who need additional large-bore IV access during surgery. EJV cannulation can provide safe and reliable IV access with a low risk of major complications in a surgical patient.</p>","PeriodicalId":7801,"journal":{"name":"Anesthesia and pain medicine","volume":"18 1","pages":"84-91"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d2/68/apm-22171.PMC9902628.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10792954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Secondary migration of a pre-existing central venous catheter due to a Swan-Ganz catheter insertion - A case report. 由于Swan-Ganz导管插入导致原有中心静脉导管继发移位- 1例报告。
Pub Date : 2023-01-01 DOI: 10.17085/apm.22212
Joonho Cho, Byung Hoon Yoo, Jihwan Park, Yun Hee Lim, In-Jung Jun, Kye-Min Kim

Background: The entanglement of multiple central venous catheters is a rare and seriouscomplication. The Swan-Ganz catheter is a responsible for various cases.

Case: A 66-year-old male patient was under general anesthesia for a coronary artery bypassgraft surgery. As he had a pre-existing Perm catheter in the right subclavian vein, a SwanGanz catheter was inserted into the left internal jugular vein. Chest radiograph after catheterplacement revealed that the Perm catheter had migrated to the left brachiocephalic vein.The surgeon attempted to reposition it manually, but postoperative radiograph showed thatit had rolled into a loop. On postoperative day 1, radiological intervention was performed tountangle the loop, which was successful.

Conclusions: After placing a Swan-Ganz catheter in patients with a pre-existing central venous catheter, the presence of entanglement should be assessed. In such cases, radiology-guided correction is recommended, as a blind attempt to disentangle can aggravate thecondition.

背景:多根中心静脉导管缠绕是一种罕见而严重的并发症。Swan-Ganz导管可用于多种病例。病例:66岁男性患者在全身麻醉下行冠状动脉旁路移植术。由于右锁骨下静脉已有Perm导管,因此将SwanGanz导管插入左颈内静脉。置管后的胸片显示Perm导管已迁移到左头臂静脉。外科医生试图手动复位,但术后x光片显示它已经卷成一个圈。术后第1天,行放射干预,成功解开袢。结论:在预先放置中心静脉导管的患者放置Swan-Ganz导管后,应评估是否存在缠结。在这种情况下,建议放射学引导的矫正,因为盲目地试图解开会加重病情。
{"title":"Secondary migration of a pre-existing central venous catheter due to a Swan-Ganz catheter insertion - A case report.","authors":"Joonho Cho,&nbsp;Byung Hoon Yoo,&nbsp;Jihwan Park,&nbsp;Yun Hee Lim,&nbsp;In-Jung Jun,&nbsp;Kye-Min Kim","doi":"10.17085/apm.22212","DOIUrl":"https://doi.org/10.17085/apm.22212","url":null,"abstract":"<p><strong>Background: </strong>The entanglement of multiple central venous catheters is a rare and seriouscomplication. The Swan-Ganz catheter is a responsible for various cases.</p><p><strong>Case: </strong>A 66-year-old male patient was under general anesthesia for a coronary artery bypassgraft surgery. As he had a pre-existing Perm catheter in the right subclavian vein, a SwanGanz catheter was inserted into the left internal jugular vein. Chest radiograph after catheterplacement revealed that the Perm catheter had migrated to the left brachiocephalic vein.The surgeon attempted to reposition it manually, but postoperative radiograph showed thatit had rolled into a loop. On postoperative day 1, radiological intervention was performed tountangle the loop, which was successful.</p><p><strong>Conclusions: </strong>After placing a Swan-Ganz catheter in patients with a pre-existing central venous catheter, the presence of entanglement should be assessed. In such cases, radiology-guided correction is recommended, as a blind attempt to disentangle can aggravate thecondition.</p>","PeriodicalId":7801,"journal":{"name":"Anesthesia and pain medicine","volume":"18 1","pages":"46-50"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/52/02/apm-22212.PMC9902637.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9287265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment experience in a patient of complex regional pain syndrome combined with secondary lymphedema of lower extremity. 复杂局部疼痛综合征合并下肢继发性淋巴水肿1例的治疗体会。
Pub Date : 2023-01-01 DOI: 10.17085/apm.22239
Ji Hee Hong, Seung Ju Kim

Background: Lymphedema is characterized by localized tissue swelling due to excessive interstitial space retention of lymphatic fluid. Lymphedema is easy to be misdiagnosed since itresembles other conditions of extremity swelling. We present a case of complex regionalpain syndrome (CRPS) type I with secondary lymphedema that was successfully managedwith spinal cord stimulation (SCS).

Case: A 39-year-old female patient came to our pain clinic with complaints of lower extremity pain and edema. To find out reason of leg edema, computed tomography of extremity angiography and blood test were performed. However, all of evaluations were normal. Lastlyperformed lymphoscintigraphy showed secondary lymphedema. SCS was performed and itshowed dramatic reduction subsequent to implantation of SCS.

Conclusions: We could successfully manage the intractable pain and edema in CRPS combined with lymphedema. If a patient presents different nature of edema, coexistence of other disease needs to be considered.

背景:淋巴水肿的特点是局部组织肿胀,由于过多的淋巴间隙潴留。淋巴水肿很容易被误诊,因为它类似于四肢肿胀的其他情况。我们报告一例伴有继发性淋巴水肿的复杂区域性疼痛综合征(CRPS) I型患者,通过脊髓刺激(SCS)成功治疗。病例:一名39岁的女性患者以下肢疼痛和水肿主诉来到我们的疼痛门诊。为查明下肢水肿的原因,行下肢血管造影及血液检查。然而,所有的评估都是正常的。最后行淋巴显像显示继发性淋巴水肿。我们进行了神经干细胞移植,发现神经干细胞移植后神经干细胞的功能显著降低。结论:我们可以成功地治疗CRPS合并淋巴水肿的顽固性疼痛和水肿。如果患者出现不同性质的水肿,则需要考虑其他疾病的共存。
{"title":"Treatment experience in a patient of complex regional pain syndrome combined with secondary lymphedema of lower extremity.","authors":"Ji Hee Hong,&nbsp;Seung Ju Kim","doi":"10.17085/apm.22239","DOIUrl":"https://doi.org/10.17085/apm.22239","url":null,"abstract":"<p><strong>Background: </strong>Lymphedema is characterized by localized tissue swelling due to excessive interstitial space retention of lymphatic fluid. Lymphedema is easy to be misdiagnosed since itresembles other conditions of extremity swelling. We present a case of complex regionalpain syndrome (CRPS) type I with secondary lymphedema that was successfully managedwith spinal cord stimulation (SCS).</p><p><strong>Case: </strong>A 39-year-old female patient came to our pain clinic with complaints of lower extremity pain and edema. To find out reason of leg edema, computed tomography of extremity angiography and blood test were performed. However, all of evaluations were normal. Lastlyperformed lymphoscintigraphy showed secondary lymphedema. SCS was performed and itshowed dramatic reduction subsequent to implantation of SCS.</p><p><strong>Conclusions: </strong>We could successfully manage the intractable pain and edema in CRPS combined with lymphedema. If a patient presents different nature of edema, coexistence of other disease needs to be considered.</p>","PeriodicalId":7801,"journal":{"name":"Anesthesia and pain medicine","volume":"18 1","pages":"70-74"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c0/50/apm-22239.PMC9902636.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10792957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultrasound diagnosis and treatment of intractable anterior chest pain from golf - A case report. 高尔夫球后顽固性胸痛的超声诊断与治疗1例。
Pub Date : 2023-01-01 DOI: 10.17085/apm.22182
Jihye Park, Su Jin Kim, Hyunho Kim, Haesun Jung, Hwa Yong Shin

Background: Pleurisy is an inflammation of the parietal pleura and is characterized by pleuritic pain. The most common cause of pleurisy is infection; other causes include rheumatoidarthritis, malignancy, rib fractures, or trauma. Possible causes of chest pain associated withgolf include costochondritis, stress fractures of the ribs, intercostal muscle strain, or, rarely,Tietze's syndrome and slipping rib syndrome.

Case: A 64-year-old female presented with intractable chest pain that began 4 months priorwhile playing golf. No specific cause was found after various examinations. There was persistent pain despite medical treatment. Ultrasonography (US) was performed over the painful areas, which revealed focal pleural effusions. A mixture of ropivacaine and triamcinolonewas injected into the focal pleural effusions using US guidance, which dramatically relievedher pain.

Conclusions: This case demonstrates that US can be used as a diagnostic and therapeuticmodality for intractable chest pain with an undetected pathology.

背景:胸膜炎是胸膜壁层的炎症,以胸膜疼痛为特征。胸膜炎最常见的原因是感染;其他原因包括类风湿关节炎、恶性肿瘤、肋骨骨折或创伤。与高尔夫相关的胸痛可能的原因包括肋软骨炎、肋骨应力性骨折、肋间肌劳损,或者罕见的Tietze综合征和肋滑动综合征。病例:64岁女性,4个月前打高尔夫球时出现顽固性胸痛。经过各种检查,没有找到具体原因。尽管进行了治疗,但疼痛仍持续存在。超声检查发现疼痛区有局灶性胸腔积液。在美国指导下,将罗哌卡因和曲安奈德的混合物注射到局灶性胸腔积液中,显著减轻了她的疼痛。结论:本病例表明US可作为一种诊断和治疗顽固性胸痛的病理未被发现的模式。
{"title":"Ultrasound diagnosis and treatment of intractable anterior chest pain from golf - A case report.","authors":"Jihye Park,&nbsp;Su Jin Kim,&nbsp;Hyunho Kim,&nbsp;Haesun Jung,&nbsp;Hwa Yong Shin","doi":"10.17085/apm.22182","DOIUrl":"https://doi.org/10.17085/apm.22182","url":null,"abstract":"<p><strong>Background: </strong>Pleurisy is an inflammation of the parietal pleura and is characterized by pleuritic pain. The most common cause of pleurisy is infection; other causes include rheumatoidarthritis, malignancy, rib fractures, or trauma. Possible causes of chest pain associated withgolf include costochondritis, stress fractures of the ribs, intercostal muscle strain, or, rarely,Tietze's syndrome and slipping rib syndrome.</p><p><strong>Case: </strong>A 64-year-old female presented with intractable chest pain that began 4 months priorwhile playing golf. No specific cause was found after various examinations. There was persistent pain despite medical treatment. Ultrasonography (US) was performed over the painful areas, which revealed focal pleural effusions. A mixture of ropivacaine and triamcinolonewas injected into the focal pleural effusions using US guidance, which dramatically relievedher pain.</p><p><strong>Conclusions: </strong>This case demonstrates that US can be used as a diagnostic and therapeuticmodality for intractable chest pain with an undetected pathology.</p>","PeriodicalId":7801,"journal":{"name":"Anesthesia and pain medicine","volume":"18 1","pages":"65-69"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/3f/91/apm-22182.PMC9902635.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10792959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of neoadjuvant chemotherapy on effect-site concentration of propofol for sedation in patients with breast cancer. 新辅助化疗对乳腺癌患者异丙酚镇静效应位点浓度的影响。
Pub Date : 2023-01-01 DOI: 10.17085/apm.22201
Myounghun Kim, Jeonghan Lee, Jinhyeok Kim, Beomseok Choi, Seunghee Ki

Background: Some studies have demonstrated that chemotherapy drugs enhance sensitivity to anesthetics owing to its systemic toxicity, while others have demonstrated that chemotherapy drugs have no effect. This study aimed to determine whether neoadjuvant chemotherapy influences the effect-site concentration (Ce) of propofol for sedation in patients withbreast cancer.

Methods: This study included patients aged 19-75 years who were scheduled to undergobreast cancer surgery under general anesthesia. Patients who received neoadjuvant chemotherapy were assigned to group C, whereas those who never received chemotherapy wereassigned to group N. Propofol was administered through an effect-site target-controlled infusion, and the Modified Observer's Assessment of Alertness/Sedation scale (MOAA/S) scoreand Bispectral Index (BIS) were recorded. When the plasma concentration and Ce wereequal to the target Ce, and if the MOAA/S score did not change, the target Ce was increasedby 0.2 μg/ml; otherwise, the Ce was maintained for 2 min and then increased. This processwas repeated until the MOAA/S score became 0.

Results: No significant differences were observed in Ce values at each sedation level between both groups. Ce values for loss of consciousness (LOC) of groups C and N were 2.76± 0.29 and 2.67 ± 0.27 μg/ml (P = 0.285), respectively. However, the BIS value at LOC ofgroup C (63.87 ± 7.04) was lower than that (68.44 ± 6.01) of group N (P = 0.018).

Conclusions: Neoadjuvant chemotherapy for breast cancer has no effect on the Ce ofpropofol for sedation.

背景:一些研究表明化疗药物由于其全身毒性而增强对麻醉剂的敏感性,而另一些研究表明化疗药物没有作用。本研究旨在确定新辅助化疗是否会影响乳腺癌患者异丙酚镇静作用的效位浓度(Ce)。方法:本研究纳入19-75岁计划在全身麻醉下接受乳腺癌手术的患者。接受新辅助化疗的患者被分配到C组,未接受化疗的患者被分配到n组。丙泊酚通过效应部位靶标控制输注,记录修改后的观察者警觉/镇静量表(MOAA/S)评分和双谱指数(BIS)。当血浆浓度和Ce与靶Ce相等,且MOAA/S评分不变时,靶Ce升高0.2 μg/ml;否则,Ce维持2 min后再升高。重复此过程,直到MOAA/S评分为0。结果:两组患者各镇静水平Ce值无显著差异。C组和N组意识丧失(LOC)的Ce值分别为2.76±0.29和2.67±0.27 μg/ml (P = 0.285)。但C组LOC处BIS值(63.87±7.04)低于N组(68.44±6.01)(P = 0.018)。结论:乳腺癌新辅助化疗对异丙酚镇静效果无影响。
{"title":"Effect of neoadjuvant chemotherapy on effect-site concentration of propofol for sedation in patients with breast cancer.","authors":"Myounghun Kim,&nbsp;Jeonghan Lee,&nbsp;Jinhyeok Kim,&nbsp;Beomseok Choi,&nbsp;Seunghee Ki","doi":"10.17085/apm.22201","DOIUrl":"https://doi.org/10.17085/apm.22201","url":null,"abstract":"<p><strong>Background: </strong>Some studies have demonstrated that chemotherapy drugs enhance sensitivity to anesthetics owing to its systemic toxicity, while others have demonstrated that chemotherapy drugs have no effect. This study aimed to determine whether neoadjuvant chemotherapy influences the effect-site concentration (Ce) of propofol for sedation in patients withbreast cancer.</p><p><strong>Methods: </strong>This study included patients aged 19-75 years who were scheduled to undergobreast cancer surgery under general anesthesia. Patients who received neoadjuvant chemotherapy were assigned to group C, whereas those who never received chemotherapy wereassigned to group N. Propofol was administered through an effect-site target-controlled infusion, and the Modified Observer's Assessment of Alertness/Sedation scale (MOAA/S) scoreand Bispectral Index (BIS) were recorded. When the plasma concentration and Ce wereequal to the target Ce, and if the MOAA/S score did not change, the target Ce was increasedby 0.2 μg/ml; otherwise, the Ce was maintained for 2 min and then increased. This processwas repeated until the MOAA/S score became 0.</p><p><strong>Results: </strong>No significant differences were observed in Ce values at each sedation level between both groups. Ce values for loss of consciousness (LOC) of groups C and N were 2.76± 0.29 and 2.67 ± 0.27 μg/ml (P = 0.285), respectively. However, the BIS value at LOC ofgroup C (63.87 ± 7.04) was lower than that (68.44 ± 6.01) of group N (P = 0.018).</p><p><strong>Conclusions: </strong>Neoadjuvant chemotherapy for breast cancer has no effect on the Ce ofpropofol for sedation.</p>","PeriodicalId":7801,"journal":{"name":"Anesthesia and pain medicine","volume":"18 1","pages":"29-36"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c7/9e/apm-22201.PMC9902627.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9286845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Choice of the correct size of endotracheal tube in pediatric patients. 为儿科患者选择正确尺寸的气管插管。
Pub Date : 2022-10-01 Epub Date: 2022-10-26 DOI: 10.17085/apm.22215
Seyeon Park, Sang-Wook Shin, Hye-Jin Kim, Gyeong-Jo Byeon, Ji-Uk Yoon, Eun-Jung Kim, Hee Young Kim

Selection and insertion of an endotracheal tube (ETT) of appropriate size for airway management during general anesthesia in pediatric patients is very important. A very small ETT increases the risk of inadequate ventilation, air leakage, and aspiration, whereas a very large ETT may cause serious complications including airway damage, post-intubation croup, and, in severe cases, subglottic stenosis. Although the pediatric larynx is conical, the narrowest part, the rima glottidis, is cylindrical in the anteroposterior dimension, regardless of development, and the cricoid ring is slightly elliptical. A cuffed ETT reduces the number of endotracheal intubation attempts, and if cuff pressure can be maintained within a safe range, the risk of airway damage may not be greater than that of an ETT without cuff. The age-based formula suggested by Cole (age/4 + 4) has long been used to select the appropriate ETT size in children. Because age-based formulas in children are not always accurate, various alternative methods for estimating the ETT size have been examined and suggested. Chest radiography, ultrasound, and a three-dimensional airway model can be used to determine the appropriate ETT size; however, there are several limitations.

在对儿科患者进行全身麻醉时,选择和插入大小合适的气管导管(ETT)以进行气道管理非常重要。过小的 ETT 会增加通气不足、漏气和吸入的风险,而过大的 ETT 则可能导致严重的并发症,包括气道损伤、插管后气管痉挛,严重时还会导致声门下狭窄。虽然小儿喉部呈圆锥形,但其最狭窄的部分(声门区)在前后维度上呈圆柱形,与发育情况无关,环甲膜环则略呈椭圆形。带充气罩囊的 ETT 可减少气管插管的次数,如果充气罩囊压力能保持在安全范围内,气道损伤的风险可能并不比不带充气罩囊的 ETT 大。长期以来,Cole 提出的基于年龄的公式(年龄/4 + 4)一直被用于为儿童选择合适的 ETT 大小。由于以儿童年龄为基础的公式并不总是准确的,因此人们研究并提出了各种估算 ETT 大小的替代方法。胸片、超声波和三维气道模型可用于确定合适的 ETT 大小;但这些方法都有一些局限性。
{"title":"Choice of the correct size of endotracheal tube in pediatric patients.","authors":"Seyeon Park, Sang-Wook Shin, Hye-Jin Kim, Gyeong-Jo Byeon, Ji-Uk Yoon, Eun-Jung Kim, Hee Young Kim","doi":"10.17085/apm.22215","DOIUrl":"10.17085/apm.22215","url":null,"abstract":"<p><p>Selection and insertion of an endotracheal tube (ETT) of appropriate size for airway management during general anesthesia in pediatric patients is very important. A very small ETT increases the risk of inadequate ventilation, air leakage, and aspiration, whereas a very large ETT may cause serious complications including airway damage, post-intubation croup, and, in severe cases, subglottic stenosis. Although the pediatric larynx is conical, the narrowest part, the rima glottidis, is cylindrical in the anteroposterior dimension, regardless of development, and the cricoid ring is slightly elliptical. A cuffed ETT reduces the number of endotracheal intubation attempts, and if cuff pressure can be maintained within a safe range, the risk of airway damage may not be greater than that of an ETT without cuff. The age-based formula suggested by Cole (age/4 + 4) has long been used to select the appropriate ETT size in children. Because age-based formulas in children are not always accurate, various alternative methods for estimating the ETT size have been examined and suggested. Chest radiography, ultrasound, and a three-dimensional airway model can be used to determine the appropriate ETT size; however, there are several limitations.</p>","PeriodicalId":7801,"journal":{"name":"Anesthesia and pain medicine","volume":" ","pages":"352-360"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/31/3c/apm-22215.PMC9663958.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40437608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Postoperative mortality in patients with end-stage renal disease according to the use of sugammadex: a single-center retrospective propensity score matched study. 使用sugammadex的终末期肾病患者的术后死亡率:一项单中心回顾性倾向评分匹配研究
Pub Date : 2022-10-01 Epub Date: 2022-10-19 DOI: 10.17085/apm.22189
Sanghoon Song, Ho Bum Cho, Sun Young Park, Wan Mo Koo, Sang Jin Choi, Sokyung Yoon, Suyeon Park, Jae Hwa Yoo, Mun Gyu Kim, Ji Won Chung, Sang Ho Kim

Background: Clearance of the sugammadex-rocuronium complex is limited to renal excretion. There are restrictions on the use of sugammadex in patients with severe renal impairment. A paucity of data supports the clinical safety of sugammadex in patients with renal impairment. We analyzed mortality after using sugammadex in patients with end-stage renal disease to establish evidence of safety for sugammadex.

Methods: We retrospectively collected the medical records of 2,134 patients with end-stage renal disease who were dependent on hemodialysis and underwent surgery under general anesthesia between January 2018 and December 2019. Propensity score matching was used. The primary outcome was the 30-day mortality rate, and secondary outcomes were the 1-year mortality rate and causes of death.

Results: A total of 2,039 patients were included in the study. Sugammadex was administered as a reversal agent for rocuronium in 806 (39.5%) patients; the remaining 1,233 (60.5%) patients did not receive sugammadex. After matching, 1,594 patients were analyzed; 28 (3.5%) of the 797 patients administered sugammadex, and 28 (3.5%) of the 797 patients without sugammadex, died within 30 days after surgery (P > 0.99); 38 (4.8%) of the 797 patients administered sugammadex, and 45 (5.7%) of the 797 patients without sugammadex, died within 1 year after surgery (P = 0.499). No significant differences in the causes of 30-day mortality were observed between the two groups after matching (P = 0.860).

Conclusions: In this retrospective study, sugammadex did not increase the 30-day and 1-year mortality rate after surgery in end-stage renal disease patients.

背景:糖madex-rocuronium复合物的清除仅限于肾脏排泄。有严重肾功能损害的患者限制使用糖madex。缺乏数据支持糖madex用于肾脏损害患者的临床安全性。我们分析了终末期肾脏疾病患者使用糖玛德后的死亡率,以建立糖玛德安全性的证据。方法:回顾性收集2018年1月至2019年12月期间2134例依赖血液透析并在全身麻醉下进行手术的终末期肾病患者的医疗记录。采用倾向评分匹配。主要结局是30天死亡率,次要结局是1年死亡率和死亡原因。结果:共纳入2039例患者。806例(39.5%)患者使用Sugammadex作为罗库溴铵的逆转剂;其余1233例(60.5%)患者未接受sugammadex治疗。匹配后,分析1594例患者;797例使用sugammadex的患者中有28例(3.5%)在术后30天内死亡,797例未使用sugammadex的患者中有28例(3.5%)在术后30天内死亡(P > 0.99);797例使用sugammadex的患者中有38例(4.8%)在术后1年内死亡,797例未使用sugammadex的患者中有45例(5.7%)在术后1年内死亡(P = 0.499)。配对后两组30天死亡原因无显著差异(P = 0.860)。结论:在这项回顾性研究中,sugammadex并没有增加终末期肾病患者术后30天和1年的死亡率。
{"title":"Postoperative mortality in patients with end-stage renal disease according to the use of sugammadex: a single-center retrospective propensity score matched study.","authors":"Sanghoon Song,&nbsp;Ho Bum Cho,&nbsp;Sun Young Park,&nbsp;Wan Mo Koo,&nbsp;Sang Jin Choi,&nbsp;Sokyung Yoon,&nbsp;Suyeon Park,&nbsp;Jae Hwa Yoo,&nbsp;Mun Gyu Kim,&nbsp;Ji Won Chung,&nbsp;Sang Ho Kim","doi":"10.17085/apm.22189","DOIUrl":"https://doi.org/10.17085/apm.22189","url":null,"abstract":"<p><strong>Background: </strong>Clearance of the sugammadex-rocuronium complex is limited to renal excretion. There are restrictions on the use of sugammadex in patients with severe renal impairment. A paucity of data supports the clinical safety of sugammadex in patients with renal impairment. We analyzed mortality after using sugammadex in patients with end-stage renal disease to establish evidence of safety for sugammadex.</p><p><strong>Methods: </strong>We retrospectively collected the medical records of 2,134 patients with end-stage renal disease who were dependent on hemodialysis and underwent surgery under general anesthesia between January 2018 and December 2019. Propensity score matching was used. The primary outcome was the 30-day mortality rate, and secondary outcomes were the 1-year mortality rate and causes of death.</p><p><strong>Results: </strong>A total of 2,039 patients were included in the study. Sugammadex was administered as a reversal agent for rocuronium in 806 (39.5%) patients; the remaining 1,233 (60.5%) patients did not receive sugammadex. After matching, 1,594 patients were analyzed; 28 (3.5%) of the 797 patients administered sugammadex, and 28 (3.5%) of the 797 patients without sugammadex, died within 30 days after surgery (P > 0.99); 38 (4.8%) of the 797 patients administered sugammadex, and 45 (5.7%) of the 797 patients without sugammadex, died within 1 year after surgery (P = 0.499). No significant differences in the causes of 30-day mortality were observed between the two groups after matching (P = 0.860).</p><p><strong>Conclusions: </strong>In this retrospective study, sugammadex did not increase the 30-day and 1-year mortality rate after surgery in end-stage renal disease patients.</p>","PeriodicalId":7801,"journal":{"name":"Anesthesia and pain medicine","volume":" ","pages":"371-380"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8e/20/apm-22189.PMC9663945.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40440115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Detection of paradoxical carbon dioxide gas embolism with opening of patent foramen ovale by perioperative transesophageal echocardiography during laparoscopic hepatectomy - A case report. 腹腔镜肝切除术围手术期经食管超声心动图检测异位二氧化碳气体栓塞伴卵圆孔未闭1例。
Pub Date : 2022-10-01 Epub Date: 2022-10-19 DOI: 10.17085/apm.22170
Haesoo Kim, Jeongyoon Lee, Sang-Gon Lee, Kwang-Seok Shim

Background: Due to its various advantages, laparoscopic surgery is preferred over laparotomy in patients who require hepatic resection. Carbon dioxide embolism -which occurs approximately ten times more often in laparoscopic hepatectomy than in general laparoscopic surgery-presents with insignificant symptoms and may be overlooked.

Case: A 70-year-old male with hepatic cell carcinoma underwent laparoscopic hepatectomy. Though his vital signs were stable during the initiation of surgery, they became unstable during the procedure. The surgeon detected portal vein rupture, and transesophageal echocardiography was subsequently performed. A large amount of gas in the heart chamber and paradoxical embolism through a patent foramen ovale due to a right-to-left shunt were observed. We treated the symptoms, and the surgery was completed without any further issues.

Conclusions: Active use of transesophageal echocardiography to identify and monitor heart functions during a suspected carbon dioxide embolism can significantly reduce morbidity and mortality associated with that embolism.

背景:由于腹腔镜手术的各种优点,在需要肝切除术的患者中,腹腔镜手术优于剖腹手术。二氧化碳栓塞——在腹腔镜肝切除术中发生的频率大约是普通腹腔镜手术的十倍——表现为不明显的症状,可能被忽视。病例:一位70岁男性肝癌患者行腹腔镜肝切除术。虽然他的生命体征在手术开始时是稳定的,但在手术过程中变得不稳定。外科医生发现门静脉破裂,随后进行了经食管超声心动图检查。我们观察到由于右至左分流引起的心腔内大量气体和通过卵圆孔未闭的矛盾栓塞。我们治疗了症状,手术完成了,没有任何进一步的问题。结论:在疑似二氧化碳栓塞时积极使用经食管超声心动图识别和监测心功能可以显著降低栓塞相关的发病率和死亡率。
{"title":"Detection of paradoxical carbon dioxide gas embolism with opening of patent foramen ovale by perioperative transesophageal echocardiography during laparoscopic hepatectomy - A case report.","authors":"Haesoo Kim,&nbsp;Jeongyoon Lee,&nbsp;Sang-Gon Lee,&nbsp;Kwang-Seok Shim","doi":"10.17085/apm.22170","DOIUrl":"https://doi.org/10.17085/apm.22170","url":null,"abstract":"<p><strong>Background: </strong>Due to its various advantages, laparoscopic surgery is preferred over laparotomy in patients who require hepatic resection. Carbon dioxide embolism -which occurs approximately ten times more often in laparoscopic hepatectomy than in general laparoscopic surgery-presents with insignificant symptoms and may be overlooked.</p><p><strong>Case: </strong>A 70-year-old male with hepatic cell carcinoma underwent laparoscopic hepatectomy. Though his vital signs were stable during the initiation of surgery, they became unstable during the procedure. The surgeon detected portal vein rupture, and transesophageal echocardiography was subsequently performed. A large amount of gas in the heart chamber and paradoxical embolism through a patent foramen ovale due to a right-to-left shunt were observed. We treated the symptoms, and the surgery was completed without any further issues.</p><p><strong>Conclusions: </strong>Active use of transesophageal echocardiography to identify and monitor heart functions during a suspected carbon dioxide embolism can significantly reduce morbidity and mortality associated with that embolism.</p>","PeriodicalId":7801,"journal":{"name":"Anesthesia and pain medicine","volume":" ","pages":"397-403"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b7/31/apm-22170.PMC9663957.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40440118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serratus anterior plane block with ultrasound-guided hydrodissection for lateral thoracic pain caused by long thoracic nerve neuropathy - A case report. 超声引导下锯肌前平面阻滞加水解剖治疗胸长神经病变所致外侧胸痛1例。
Pub Date : 2022-10-01 Epub Date: 2022-10-06 DOI: 10.17085/apm.21120
Minsoo Kim, Daehun Goh, Soyeon Cho, Yeonji Noh, Byeongmun Hwang

Background: Long thoracic nerve (LTN) neuropathy occasionally occurs in young people who engage in various sports. It may have a traumatic or non-traumatic etiology. The landmark manifestation of LTN neuropathy is scapular winging; however, it can also occur without scapular winging and specific magnetic resonance imaging findings.

Case: An 18-year-old male complained of right-sided lateral chest pain for 7 months. He was treated with medication, trigger point injection, and physical therapy but showed no improvement. Electromyelogram findings suggested LTN neuropathy in the right lateral chest. We performed a serratus anterior (SA) plane block with ultrasound (US)-guided hydrodissection and achieved pain relief.

Conclusions: We report the successful treatment of LTN neuropathy with an SA plane block and US-guided hydrodissection.

背景:长胸神经(LTN)神经病偶尔发生在从事各种运动的年轻人中。它可能有创伤性或非创伤性病因。LTN神经病的标志性表现为肩胛骨翅;然而,它也可以发生在没有肩胛骨翅膀和特定的磁共振成像结果。病例:一名18岁男性主诉右侧胸痛7个月。他接受了药物治疗、触发点注射和物理治疗,但没有任何改善。脊髓电图显示右胸外侧有LTN神经病。我们采用超声引导下的前锯肌(SA)平面阻滞进行水解剖,疼痛得到缓解。结论:我们报告用SA平面阻滞和us引导下的水解剖成功治疗LTN神经病变。
{"title":"Serratus anterior plane block with ultrasound-guided hydrodissection for lateral thoracic pain caused by long thoracic nerve neuropathy - A case report.","authors":"Minsoo Kim,&nbsp;Daehun Goh,&nbsp;Soyeon Cho,&nbsp;Yeonji Noh,&nbsp;Byeongmun Hwang","doi":"10.17085/apm.21120","DOIUrl":"https://doi.org/10.17085/apm.21120","url":null,"abstract":"<p><strong>Background: </strong>Long thoracic nerve (LTN) neuropathy occasionally occurs in young people who engage in various sports. It may have a traumatic or non-traumatic etiology. The landmark manifestation of LTN neuropathy is scapular winging; however, it can also occur without scapular winging and specific magnetic resonance imaging findings.</p><p><strong>Case: </strong>An 18-year-old male complained of right-sided lateral chest pain for 7 months. He was treated with medication, trigger point injection, and physical therapy but showed no improvement. Electromyelogram findings suggested LTN neuropathy in the right lateral chest. We performed a serratus anterior (SA) plane block with ultrasound (US)-guided hydrodissection and achieved pain relief.</p><p><strong>Conclusions: </strong>We report the successful treatment of LTN neuropathy with an SA plane block and US-guided hydrodissection.</p>","PeriodicalId":7801,"journal":{"name":"Anesthesia and pain medicine","volume":" ","pages":"434-438"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6e/b7/apm-21120.PMC9663951.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40460480","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Electroconvulsive therapy in a catatonia patient: succinylcholine or no succinylcholine? 电痉挛治疗紧张症患者:琥珀胆碱还是不琥珀胆碱?
Pub Date : 2022-10-01 Epub Date: 2022-09-20 DOI: 10.17085/apm.22202
Manbir Kaur, Swati Chhabra, Pradeep Bhatia, Ravindra Singh Chouhan
by Joung et al. [1] published in Anesthesia & Pain Medicine. We wish to describe our experience with different anesthetic drugs and techniques in a patient with catatonia undergoing multiple electroconvulsive therapy (ECT) sessions. Catatonia is characterized by a constellation of psychomotor disturbances associated with immobility, mutism, and rigidity [2]. ECT is the preferred treatment modality [2]. As patients with catatonia are prone to muscle rigidity, hyperkalemia, and deteriorating Glasgow coma scale (GCS) score, anesthesia is challenging for ECT procedures [3]. A 48-year-old female patient weighing 35 kg presented with hallucinations, dementia, and increased muscle rigidity in all four limbs for the past 6 months and was diagnosed with catatonia (secondary to Lewy bodies in the substantia nigra). As the patient was resistant to pharmacological therapy (lorazepam, escitalopram, and syndopa), ECT was finally planned. Her GCS score was E4V1M5. As routine blood investigations were normal, our main concern was serum potassium (4.45 mEq/L), which was expected to rise further with succinylcholine, a commonly used neuromuscular blocking drug (NMBD) in ECT procedures [2]. In her first ECT session, succinylcholine was avoided because of the reported risk of life-threatening hyperkalemia as a result of upregulation of nicotinic cholinergic receptors secondary to long-term immobilization (as the patient was immobilized for the past 6 months). Glycopyrrolate (0.2 mg), propofol (80 mg), and atracurium (15 mg) were administered to the patient. I-gel insertion and propofol infusion were started for maintenance until recovery from neuromuscular blockade. After the procedure, the patient recovered to her preoperative GCS score. In the second ECT session, the same anesthesia technique was used. There was no improvement in the GCS score after two ECT sessions although an improvement in muscle rigidity was observed. In the third ECT session, it was decided to use succinylcholine instead of atracurium with complete preparation for monitoring, diagnosis, and management of hyperkalemia, in case Letter to the Editor Anesth Pain Med 2022;17:454-455 https://doi.org/10.17085/apm.22202 pISSN 1975-5171 • eISSN 2383-7977
{"title":"Electroconvulsive therapy in a catatonia patient: succinylcholine or no succinylcholine?","authors":"Manbir Kaur,&nbsp;Swati Chhabra,&nbsp;Pradeep Bhatia,&nbsp;Ravindra Singh Chouhan","doi":"10.17085/apm.22202","DOIUrl":"https://doi.org/10.17085/apm.22202","url":null,"abstract":"by Joung et al. [1] published in Anesthesia & Pain Medicine. We wish to describe our experience with different anesthetic drugs and techniques in a patient with catatonia undergoing multiple electroconvulsive therapy (ECT) sessions. Catatonia is characterized by a constellation of psychomotor disturbances associated with immobility, mutism, and rigidity [2]. ECT is the preferred treatment modality [2]. As patients with catatonia are prone to muscle rigidity, hyperkalemia, and deteriorating Glasgow coma scale (GCS) score, anesthesia is challenging for ECT procedures [3]. A 48-year-old female patient weighing 35 kg presented with hallucinations, dementia, and increased muscle rigidity in all four limbs for the past 6 months and was diagnosed with catatonia (secondary to Lewy bodies in the substantia nigra). As the patient was resistant to pharmacological therapy (lorazepam, escitalopram, and syndopa), ECT was finally planned. Her GCS score was E4V1M5. As routine blood investigations were normal, our main concern was serum potassium (4.45 mEq/L), which was expected to rise further with succinylcholine, a commonly used neuromuscular blocking drug (NMBD) in ECT procedures [2]. In her first ECT session, succinylcholine was avoided because of the reported risk of life-threatening hyperkalemia as a result of upregulation of nicotinic cholinergic receptors secondary to long-term immobilization (as the patient was immobilized for the past 6 months). Glycopyrrolate (0.2 mg), propofol (80 mg), and atracurium (15 mg) were administered to the patient. I-gel insertion and propofol infusion were started for maintenance until recovery from neuromuscular blockade. After the procedure, the patient recovered to her preoperative GCS score. In the second ECT session, the same anesthesia technique was used. There was no improvement in the GCS score after two ECT sessions although an improvement in muscle rigidity was observed. In the third ECT session, it was decided to use succinylcholine instead of atracurium with complete preparation for monitoring, diagnosis, and management of hyperkalemia, in case Letter to the Editor Anesth Pain Med 2022;17:454-455 https://doi.org/10.17085/apm.22202 pISSN 1975-5171 • eISSN 2383-7977","PeriodicalId":7801,"journal":{"name":"Anesthesia and pain medicine","volume":" ","pages":"454-455"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9e/34/apm-22202.PMC9663952.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40460482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Anesthesia and pain medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1